Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Crude Heparin Market Size(US$)
CAGR 2024-2030
6.2%
Market Size,2030
USD 5,474.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 3,818 million
Market Forecast in 2030(Value)
US$ 5,474.4 million
CAGR
6.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The global Crude Heparin market is projected to reach US$ 5474.4 million by 2030 from an estimated US$ 3818 million in 2024, at a CAGR of 6.2% during 2024 and 2030.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology. The top three players hold a share about 30%. The global crude heparin products are mainly produced in Europe and China. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 90%.
Market Segmentation
By Company
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Segment by Application
- UFH
- LMWH
Report Scope
This report aims to provide a comprehensive presentation of the global market for Crude Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Crude Heparin.
The Crude Heparin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crude Heparin market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crude Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Crude Heparin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crude Heparin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Crude Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Crude Heparin Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Market by Application
1.3.1 Global Crude Heparin Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 UFH
1.3.3 LMWH
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Crude Heparin Market Size Estimates and Forecasts
2.1.1 Global Crude Heparin Revenue 2019-2030
2.1.2 Global Crude Heparin Sales 2019-2030
2.2 Crude Heparin Market Size by Region: 2023 Versus 2030
2.3 Crude Heparin Sales by Region (2019-2030)
2.3.1 Global Crude Heparin Sales by Region: 2019-2024
2.3.2 Global Crude Heparin Sales Forecast by Region (2025-2030)
2.3.3 Global Crude Heparin Sales Market Share by Region (2019-2030)
2.4 Crude Heparin Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Crude Heparin Revenue by Region: 2019-2024
2.4.2 Global Crude Heparin Revenue Forecast by Region (2025-2030)
2.4.3 Global Crude Heparin Revenue Market Share by Region (2019-2030)
3 Global Crude Heparin by Manufacturers
3.1 Global Top Crude Heparin Manufacturers by Sales
3.1.1 Global Crude Heparin Sales by Manufacturer (2019-2024)
3.1.2 Global Crude Heparin Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Crude Heparin Manufacturers by Revenue
3.2.1 Global Crude Heparin Revenue by Manufacturer (2019-2024)
3.2.2 Global Crude Heparin Revenue Share by Manufacturer (2019-2024)
3.3 Global Crude Heparin Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Crude Heparin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Crude Heparin Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Crude Heparin Manufacturing Base Distribution, Product Type
3.5.1 Crude Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Crude Heparin Product Type
3.5.3 Date of International Manufacturers Enter into Crude Heparin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bioiberica
4.1.1 Bioiberica Company Information
4.1.2 Bioiberica Description, Business Overview
4.1.3 Bioiberica Crude Heparin Products Offered
4.1.4 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Bioiberica Crude Heparin Sales by Product in 2023
4.1.6 Bioiberica Crude Heparin Sales by Application in 2023
4.1.7 Bioiberica Crude Heparin Sales by Geographic Area in 2023
4.1.8 Bioiberica Recent Developments
4.2 Shenzhen Hepalink
4.2.1 Shenzhen Hepalink Company Information
4.2.2 Shenzhen Hepalink Description, Business Overview
4.2.3 Shenzhen Hepalink Crude Heparin Products Offered
4.2.4 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Shenzhen Hepalink Crude Heparin Sales by Product in 2023
4.2.6 Shenzhen Hepalink Crude Heparin Sales by Application in 2023
4.2.7 Shenzhen Hepalink Crude Heparin Sales by Geographic Area in 2023
4.2.8 Shenzhen Hepalink Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Description, Business Overview
4.3.3 Sanofi Crude Heparin Products Offered
4.3.4 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Sanofi Crude Heparin Sales by Product in 2023
4.3.6 Sanofi Crude Heparin Sales by Application in 2023
4.3.7 Sanofi Crude Heparin Sales by Geographic Area in 2023
4.3.8 Sanofi Recent Developments
4.4 Nanjing King-friend
4.4.1 Nanjing King-friend Company Information
4.4.2 Nanjing King-friend Description, Business Overview
4.4.3 Nanjing King-friend Crude Heparin Products Offered
4.4.4 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Nanjing King-friend Crude Heparin Sales by Product in 2023
4.4.6 Nanjing King-friend Crude Heparin Sales by Application in 2023
4.4.7 Nanjing King-friend Crude Heparin Sales by Geographic Area in 2023
4.4.8 Nanjing King-friend Recent Developments
4.5 Fengrun Biological Technology
4.5.1 Fengrun Biological Technology Company Information
4.5.2 Fengrun Biological Technology Description, Business Overview
4.5.3 Fengrun Biological Technology Crude Heparin Products Offered
4.5.4 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Fengrun Biological Technology Crude Heparin Sales by Product in 2023
4.5.6 Fengrun Biological Technology Crude Heparin Sales by Application in 2023
4.5.7 Fengrun Biological Technology Crude Heparin Sales by Geographic Area in 2023
4.5.8 Fengrun Biological Technology Recent Developments
4.6 Aspen Oss
4.6.1 Aspen Oss Company Information
4.6.2 Aspen Oss Description, Business Overview
4.6.3 Aspen Oss Crude Heparin Products Offered
4.6.4 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Aspen Oss Crude Heparin Sales by Product in 2023
4.6.6 Aspen Oss Crude Heparin Sales by Application in 2023
4.6.7 Aspen Oss Crude Heparin Sales by Geographic Area in 2023
4.6.8 Aspen Oss Recent Development
4.7 Hebei Changshan Biochemical
4.7.1 Hebei Changshan Biochemical Company Information
4.7.2 Hebei Changshan Biochemical Description, Business Overview
4.7.3 Hebei Changshan Biochemical Crude Heparin Products Offered
4.7.4 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Hebei Changshan Biochemical Crude Heparin Sales by Product in 2023
4.7.6 Hebei Changshan Biochemical Crude Heparin Sales by Application in 2023
4.7.7 Hebei Changshan Biochemical Crude Heparin Sales by Geographic Area in 2023
4.7.8 Hebei Changshan Biochemical Recent Development
4.8 Changzhou Qianhong
4.8.1 Changzhou Qianhong Company Information
4.8.2 Changzhou Qianhong Description, Business Overview
4.8.3 Changzhou Qianhong Crude Heparin Products Offered
4.8.4 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Changzhou Qianhong Crude Heparin Sales by Product in 2023
4.8.6 Changzhou Qianhong Crude Heparin Sales by Application in 2023
4.8.7 Changzhou Qianhong Crude Heparin Sales by Geographic Area in 2023
4.8.8 Changzhou Qianhong Recent Development
4.9 Hepac (Darling Ingredients)
4.9.1 Hepac (Darling Ingredients) Company Information
4.9.2 Hepac (Darling Ingredients) Description, Business Overview
4.9.3 Hepac (Darling Ingredients) Crude Heparin Products Offered
4.9.4 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Hepac (Darling Ingredients) Crude Heparin Sales by Product in 2023
4.9.6 Hepac (Darling Ingredients) Crude Heparin Sales by Application in 2023
4.9.7 Hepac (Darling Ingredients) Crude Heparin Sales by Geographic Area in 2023
4.9.8 Hepac (Darling Ingredients) Recent Development
4.10 Huaian MDC Pharmaceutical
4.10.1 Huaian MDC Pharmaceutical Company Information
4.10.2 Huaian MDC Pharmaceutical Description, Business Overview
4.10.3 Huaian MDC Pharmaceutical Crude Heparin Products Offered
4.10.4 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.10.5 Huaian MDC Pharmaceutical Crude Heparin Sales by Product in 2023
4.10.6 Huaian MDC Pharmaceutical Crude Heparin Sales by Application in 2023
4.10.7 Huaian MDC Pharmaceutical Crude Heparin Sales by Geographic Area in 2023
4.10.8 Huaian MDC Pharmaceutical Recent Development
4.11 Yantai Dongcheng Biochemicals
4.11.1 Yantai Dongcheng Biochemicals Company Information
4.11.2 Yantai Dongcheng Biochemicals Description, Business Overview
4.11.3 Yantai Dongcheng Biochemicals Crude Heparin Products Offered
4.11.4 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Yantai Dongcheng Biochemicals Crude Heparin Sales by Product in 2023
4.11.6 Yantai Dongcheng Biochemicals Crude Heparin Sales by Application in 2023
4.11.7 Yantai Dongcheng Biochemicals Crude Heparin Sales by Geographic Area in 2023
4.11.8 Yantai Dongcheng Biochemicals Recent Development
5 Breakdown Data by Type
5.1 Global Crude Heparin Sales by Type (2019-2030)
5.1.1 Global Crude Heparin Sales by Type (2019-2024)
5.1.2 Global Crude Heparin Sales Forecast by Type (2025-2030)
5.1.3 Global Crude Heparin Sales Market Share by Type (2019-2030)
5.2 Global Crude Heparin Revenue Forecast by Type (2019-2030)
5.2.1 Global Crude Heparin Revenue by Type (2019-2024)
5.2.2 Global Crude Heparin Revenue Forecast by Type (2025-2030)
5.2.3 Global Crude Heparin Revenue Market Share by Type (2019-2030)
5.3 Crude Heparin Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Crude Heparin Sales by Application (2019-2030)
6.1.1 Global Crude Heparin Sales by Application (2019-2024)
6.1.2 Global Crude Heparin Sales Forecast by Application (2025-2030)
6.1.3 Global Crude Heparin Sales Market Share by Application (2019-2030)
6.2 Global Crude Heparin Revenue Forecast by Application (2019-2030)
6.2.1 Global Crude Heparin Revenue by Application (2019-2024)
6.2.2 Global Crude Heparin Revenue Forecast by Application (2025-2030)
6.2.3 Global Crude Heparin Revenue Market Share by Application (2019-2030)
6.3 Crude Heparin Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Crude Heparin Market Size YoY Growth 2019-2030
7.2 North America Crude Heparin Market Facts & Figures by Country
7.2.1 North America Crude Heparin Sales by Country (2019-2030)
7.2.2 North America Crude Heparin Revenue by Country (2019-2030)
7.3 North America Crude Heparin Sales by Type (2019-2024)
7.4 North America Crude Heparin Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Crude Heparin Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Crude Heparin Market Facts & Figures by Region
8.2.1 Asia-Pacific Crude Heparin Sales by Region (2019-2030)
8.2.2 Asia-Pacific Crude Heparin Revenue by Region (2019-2030)
8.3 Asia-Pacific Crude Heparin Sales by Type (2019-2024)
8.4 Asia-Pacific Crude Heparin Sales by Application (2019-2024)
9 Europe
9.1 Europe Crude Heparin Market Size YoY Growth 2019-2030
9.2 Europe Crude Heparin Market Facts & Figures by Country
9.2.1 Europe Crude Heparin Sales by Country (2019-2030)
9.2.2 Europe Crude Heparin Revenue by Country (2019-2030)
9.3 Europe Crude Heparin Sales by Type (2019-2024)
9.4 Europe Crude Heparin Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Crude Heparin Market Size YoY Growth 2019-2030
10.2 Latin America Crude Heparin Market Facts & Figures by Country
10.2.1 Latin America Crude Heparin Sales by Country (2019-2030)
10.2.2 Latin America Crude Heparin Revenue by Country (2019-2030)
10.3 Latin America Crude Heparin Sales by Type (2019-2024)
10.4 Latin America Crude Heparin Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Crude Heparin Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Crude Heparin Market Facts & Figures by Country
11.2.1 Middle East and Africa Crude Heparin Sales by Country (2019-2030)
11.2.2 Middle East and Africa Crude Heparin Revenue by Country (2019-2030)
11.3 Middle East and Africa Crude Heparin Sales by Type (2019-2024)
11.4 Middle East and Africa Crude Heparin Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Crude Heparin Supply Chain Analysis
12.2 Crude Heparin Key Raw Materials and Upstream Suppliers
12.3 Crude Heparin Clients Analysis
12.4 Crude Heparin Sales Channel and Sales Model Analysis
12.4.1 Crude Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Crude Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Crude Heparin Distributors
13 Market Dynamics
13.1 Crude Heparin Industry Trends
13.2 Crude Heparin Market Drivers
13.3 Crude Heparin Market Challenges
13.4 Crude Heparin Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Crude Heparin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Manufacturers of Pig Intestine Mucosa Heparin
Table 3. Major Manufacturers of Bovine Heparin and Others
Table 4. Global Crude Heparin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Crude Heparin Market Size by Region (US$ Million): 2023 VS 2030
Table 6. Global Crude Heparin Sales by Region (2019-2024) & (Tons)
Table 7. Global Crude Heparin Sales Forecast by Region (2025-2030) & (Tons)
Table 8. Global Crude Heparin Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Crude Heparin Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 10. Global Crude Heparin Sales by Manufacturer (2019-2024) & (Tons)
Table 11. Global Crude Heparin Sales Share by Manufacturer (2019-2024)
Table 12. Crude Heparin Revenue by Manufacturer (2019-2024) & (US$ Million)
Table 13. Crude Heparin Revenue Share by Manufacturer (2019-2024)
Table 14. Key Manufacturers Crude Heparin Price (2019-2024) & (US$/Kg)
Table 15. Ranking of Global Top Crude Heparin Manufacturers by Revenue (US$ Million) in 2023
Table 16. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 17. Global Crude Heparin by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Crude Heparin as of 2023)
Table 18. Crude Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Crude Heparin Product Type
Table 20. Date of International Manufacturers Enter into Crude Heparin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Bioiberica Company Information
Table 23. Bioiberica Description and Business Overview
Table 24. Bioiberica Crude Heparin Product
Table 25. Bioiberica Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 26. Bioiberica Sales Proportion of Crude Heparin by Product in 2023
Table 27. Bioiberica Sales Proportion of Crude Heparin by Application in 2023
Table 28. Bioiberica Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 29. Bioiberica Recent Development
Table 30. Shenzhen Hepalink Company Information
Table 31. Shenzhen Hepalink Description and Business Overview
Table 32. Shenzhen Hepalink Crude Heparin Product
Table 33. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 34. Shenzhen Hepalink Sales Proportion of Crude Heparin by Product in 2023
Table 35. Shenzhen Hepalink Sales Proportion of Crude Heparin by Application in 2023
Table 36. Shenzhen Hepalink Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 37. Shenzhen Hepalink Recent Development
Table 38. Sanofi Company Information
Table 39. Sanofi Description and Business Overview
Table 40. Sanofi Crude Heparin Product
Table 41. Sanofi Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 42. Sanofi Sales Proportion of Crude Heparin by Product in 2023
Table 43. Sanofi Sales Proportion of Crude Heparin by Application in 2023
Table 44. Sanofi Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 45. Sanofi Recent Development
Table 46. Nanjing King-friend Company Information
Table 47. Nanjing King-friend Description and Business Overview
Table 48. Nanjing King-friend Crude Heparin Product
Table 49. Nanjing King-friend Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 50. Nanjing King-friend Sales Proportion of Crude Heparin by Product in 2023
Table 51. Nanjing King-friend Sales Proportion of Crude Heparin by Application in 2023
Table 52. Nanjing King-friend Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 53. Nanjing King-friend Recent Development
Table 54. Fengrun Biological Technology Company Information
Table 55. Fengrun Biological Technology Description and Business Overview
Table 56. Fengrun Biological Technology Crude Heparin Product
Table 57. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 58. Fengrun Biological Technology Sales Proportion of Crude Heparin by Product in 2023
Table 59. Fengrun Biological Technology Sales Proportion of Crude Heparin by Application in 2023
Table 60. Fengrun Biological Technology Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 61. Fengrun Biological Technology Recent Development
Table 62. Aspen Oss Company Information
Table 63. Aspen Oss Description and Business Overview
Table 64. Aspen Oss Crude Heparin Product
Table 65. Aspen Oss Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 66. Aspen Oss Sales Proportion of Crude Heparin by Product in 2023
Table 67. Aspen Oss Sales Proportion of Crude Heparin by Application in 2023
Table 68. Aspen Oss Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 69. Aspen Oss Recent Development
Table 70. Hebei Changshan Biochemical Company Information
Table 71. Hebei Changshan Biochemical Description and Business Overview
Table 72. Hebei Changshan Biochemical Crude Heparin Product
Table 73. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 74. Hebei Changshan Biochemical Sales Proportion of Crude Heparin by Product in 2023
Table 75. Hebei Changshan Biochemical Sales Proportion of Crude Heparin by Application in 2023
Table 76. Hebei Changshan Biochemical Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 77. Hebei Changshan Biochemical Recent Development
Table 78. Changzhou Qianhong Company Information
Table 79. Changzhou Qianhong Description and Business Overview
Table 80. Changzhou Qianhong Crude Heparin Product
Table 81. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 82. Changzhou Qianhong Sales Proportion of Crude Heparin by Product in 2023
Table 83. Changzhou Qianhong Sales Proportion of Crude Heparin by Application in 2023
Table 84. Changzhou Qianhong Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 85. Changzhou Qianhong Recent Development
Table 86. Hepac (Darling Ingredients) Company Information
Table 87. Hepac (Darling Ingredients) Description and Business Overview
Table 88. Hepac (Darling Ingredients) Crude Heparin Product
Table 89. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Hepac (Darling Ingredients) Sales Proportion of Crude Heparin by Product in 2023
Table 91. Hepac (Darling Ingredients) Sales Proportion of Crude Heparin by Application in 2023
Table 92. Hepac (Darling Ingredients) Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 93. Hepac (Darling Ingredients) Recent Development
Table 94. Huaian MDC Pharmaceutical Company Information
Table 95. Huaian MDC Pharmaceutical Description and Business Overview
Table 96. Huaian MDC Pharmaceutical Crude Heparin Product
Table 97. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Huaian MDC Pharmaceutical Sales Proportion of Crude Heparin by Product in 2023
Table 99. Huaian MDC Pharmaceutical Sales Proportion of Crude Heparin by Application in 2023
Table 100. Huaian MDC Pharmaceutical Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 101. Huaian MDC Pharmaceutical Recent Development
Table 102. Yantai Dongcheng Biochemicals Company Information
Table 103. Yantai Dongcheng Biochemicals Description and Business Overview
Table 104. Yantai Dongcheng Biochemicals Crude Heparin Product
Table 105. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 106. Yantai Dongcheng Biochemicals Sales Proportion of Crude Heparin by Product in 2023
Table 107. Yantai Dongcheng Biochemicals Sales Proportion of Crude Heparin by Application in 2023
Table 108. Yantai Dongcheng Biochemicals Sales Proportion of Crude Heparin by Geographic Area in 2023
Table 109. Yantai Dongcheng Biochemicals Recent Development
Table 110. Global Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 111. Global Crude Heparin Sales Forecast by Type (2025-2030) & (Tons)
Table 112. Global Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 113. Global Crude Heparin Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 114. Global Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 115. Global Crude Heparin Sales Forecast by Application (2025-2030) & (Tons)
Table 116. Global Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 117. Global Crude Heparin Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 118. North America Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 119. North America Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 120. North America Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 121. North America Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 122. North America Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 123. North America Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 124. Asia-Pacific Crude Heparin Sales by Region (2019-2024) & (Tons)
Table 125. Asia-Pacific Crude Heparin Sales by Region (2025-2030) & (Tons)
Table 126. Asia-Pacific Crude Heparin Revenue by Region (2019-2030) & (US$ Million)
Table 127. Asia-Pacific Crude Heparin Revenue by Region (2025-2030) & (US$ Million)
Table 128. Asia-Pacific Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 129. Asia-Pacific Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 130. Europe Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 131. Europe Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 132. Europe Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 133. Europe Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 134. Europe Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 135. Europe Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 136. Latin America Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 137. Latin America Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 138. Latin America Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 139. Latin America Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 140. Latin America Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 141. Latin America Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 142. Middle East and Africa Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 143. Middle East and Africa Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 144. Middle East and Africa Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 145. Middle East and Africa Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 146. Middle East and Africa Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 147. Middle East and Africa Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 148. Crude Heparin Key Raw Materials, Industry Status and Trend
Table 149. Crude Heparin Key Raw Materials and Upstream Suppliers
Table 150. Crude Heparin Clients Status and Trend
Table 151. Crude Heparin Typical Clients
Table 152. Crude Heparin Distributors
Table 153. Crude Heparin Market Trends
Table 154. Crude Heparin Market Drivers
Table 155. Crude Heparin Market Challenges
Table 156. Crude Heparin Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Sales Market Share by Type in 2023 & 2030
Figure 3. Pig Intestine Mucosa Heparin Product Picture
Figure 4. Bovine Heparin and Others Product Picture
Figure 5. Global Crude Heparin Sales Market Share by Application in 2023 & 2030
Figure 6. UFH Examples
Figure 7. LMWH Examples
Figure 8. Crude Heparin Report Years Considered
Figure 9. Global Crude Heparin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global Crude Heparin Market Size 2019-2030 (US$ Million)
Figure 11. Global Crude Heparin Sales 2019-2030 (Tons)
Figure 12. Global Crude Heparin Sales Market Share Forecast by Region (2019-2030)
Figure 13. Global Crude Heparin Revenue Market Share by Region (2019-2030)
Figure 14. Global Crude Heparin Sales Share by Manufacturer in 2023
Figure 15. Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 16. Global Crude Heparin Sales Market Share Forecast by Type (2019-2030)
Figure 17. Global Crude Heparin Revenue Market Share Forecast by Type (2019-2030)
Figure 18. Crude Heparin Average Selling Price (ASP) by Type (2019-2024) & (US$/Kg)
Figure 19. Global Crude Heparin Sales Market Share Forecast by Application (2019-2030)
Figure 20. Global Crude Heparin Revenue Market Share Forecast by Application (2019-2030)
Figure 21. Crude Heparin Average Selling Price (ASP) by Application (2019-2024) & (US$/Kg)
Figure 22. North America Crude Heparin Revenue 2019-2030 (US$ Million)
Figure 23. North America Crude Heparin Sales Market Share by Type (2019-2024)
Figure 24. North America Crude Heparin Sales Market Share by Application (2019-2024)
Figure 25. Asia-Pacific Crude Heparin Revenue 2019-2030 (US$ Million)
Figure 26. Asia-Pacific Crude Heparin Sales Market Share by Region (2019-2030)
Figure 27. Asia-Pacific Crude Heparin Revenue Market Share by Region (2019-2030)
Figure 28. Asia-Pacific Crude Heparin Sales Market Share by Type (2019-2024)
Figure 29. Asia-Pacific Crude Heparin Sales Market Share by Application (2019-2024)
Figure 30. Europe Crude Heparin Revenue Growth Rate 2019-2030 (US$ Million)
Figure 31. Europe Crude Heparin Sales Market Share by Country (2019-2030)
Figure 32. Europe Crude Heparin Revenue Market Share by Country (2019-2030)
Figure 33. Europe Crude Heparin Sales Market Share by Type (2019-2024)
Figure 34. Europe Crude Heparin Sales Market Share by Application (2019-2024)
Figure 35. Latin America Crude Heparin Revenue Growth Rate 2019-2030 (US$ Million)
Figure 36. Latin America Crude Heparin Sales Market Share by Country (2019-2030)
Figure 37. Latin America Crude Heparin Revenue Market Share by Country (2019-2024)
Figure 38. Latin America Crude Heparin Sales Market Share by Type (2019-2024)
Figure 39. Latin America Crude Heparin Sales Market Share by Application (2019-2024)
Figure 40. Middle East and Africa Crude Heparin Revenue Growth Rate 2019-2030 (US$ Million)
Figure 41. Middle East and Africa Crude Heparin Sales Market Share by Country (2019-2030)
Figure 42. Middle East and Africa Crude Heparin Revenue Market Share by Country (2019-2030)
Figure 43. Middle East and Africa Crude Heparin Sales Market Share by Type (2019-2024)
Figure 44. Middle East and Africa Crude Heparin Sales Market Share by Application (2019-2024)
Figure 45. Crude Heparin Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Crude Heparin Raw Materials by Region in 2023
Figure 47. Crude Heparin Distribution Channels
Figure 48. Global Crude Heparin Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 49. Global Crude Heparin Percentage 2019-2030: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Related Reports
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-07
Pages: 108
USD 4900.00
(Single User License)
Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-17
Pages: 159
USD 5600.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 128
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 164
USD 4900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 124
USD 2900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-07
Pages: 108
USD 4900.00 (Single User License)Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-17
Pages: 159
USD 5600.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 128
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-18
Pages: 88
USD 2900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 164
USD 4900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 124
USD 2900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Report Scope
Chapter Outline
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research